Skip to main content
Hualan Biological Engineering Inc. logo

Hualan Biological Engineering Inc. — Investor Relations & Filings

Ticker · 002007 ISIN · CNE000001JN8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,526 across all filing types
Latest filing 2025-06-20 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002007

About Hualan Biological Engineering Inc.

https://www.hualanbio.com

Hualan Biological Engineering Inc. is a biopharmaceutical enterprise specializing in the research, development, production, and commercialization of blood products and vaccines. The company’s portfolio is divided into two primary segments: plasma-derived therapeutics and viral vaccines. Key blood products include human albumin, intravenous immunoglobulin (IVIG), human coagulation factor VIII, and prothrombin complex. In the vaccine sector, the company produces seasonal influenza vaccines, including quadrivalent formulations, as well as hepatitis B and rabies vaccines. Hualan Biological Engineering operates advanced manufacturing facilities and plasma collection centers, focusing on high-quality standards and technological innovation in recombinant protein drugs and monoclonal antibodies to address critical medical needs in immunology, hematology, and infectious disease prevention.

Recent filings

Filing Released Lang Actions
外部信息报送和使用管理制度
Regulatory Filings Classification · 95% confidence The document is a detailed internal policy and management system regarding the handling, reporting, and confidentiality of external information submissions by the company. It references laws and regulations related to information disclosure and insider trading, and includes confidentiality notice templates and commitment letters. There is no financial data, no report or announcement of financial results, no voting results, no management changes, no legal proceedings, no capital updates, or any other specific filing content. The document is a regulatory compliance and internal governance document related to information disclosure management. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or others that require financial data or specific event announcements. It is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory and compliance documents that do not fit other categories.
2025-06-20 Chinese
关于董事会换届选举的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of the company's new board of directors, detailing the nomination and qualifications of candidates for the ninth board term. It includes information about the board composition, election procedures, and candidate biographies. There is no financial data or report content, but rather a formal notice about board member changes and upcoming shareholder vote. This fits the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document length is 3356 characters, consistent with a detailed announcement rather than a full report. Therefore, the correct classification is MANG.
2025-06-20 Chinese
重大投资决策制度
Governance Information Classification · 95% confidence The document is a detailed internal policy document titled '重大投资决策制度' (Major Investment Decision System) of 华兰生物工程股份有限公司. It outlines the company's internal rules, procedures, and governance related to major investment decisions, including decision-making authority, approval thresholds, implementation, and supervision. There is no indication that this is a financial report, earnings release, or regulatory filing. It is not an announcement or a certification but a governance document describing internal control and decision-making processes. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-06-20 Chinese
董事会审计委员会工作细则
Governance Information Classification · 95% confidence The document is titled '董事会审计委员会工作细则' which translates to 'Board Audit Committee Working Rules'. It details the structure, responsibilities, procedures, and authority of the audit committee within the board of directors. The content focuses on governance, internal controls, audit oversight, and committee operations rather than presenting financial statements or audit results. There is no indication of it being an audit report, annual report, or any financial statement. It is a governance-related document outlining internal rules and practices of the audit committee, which fits the definition of Governance Information (CGR). The document length is 4164 characters, which is sufficient for a detailed governance report rather than a brief announcement or notice. Therefore, the classification is Governance Information (CGR) with high confidence.
2025-06-20 Chinese
内部审计制度
Governance Information Classification · 95% confidence The document is titled '内部审计制度' which translates to 'Internal Audit System' or 'Internal Audit Policy' of the company 华兰生物工程股份有限公司. It details the internal audit framework, responsibilities, scope, procedures, and governance related to internal audit activities within the company. It references laws and regulations related to auditing and internal controls but does not contain financial statements, audit opinions, or results of external audits. It is a governance and procedural document outlining internal audit policies rather than an audit report or annual report. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-06-20 Chinese
独立董事候选人声明（苏志国）
Board/Management Information Classification · 95% confidence The document is a detailed declaration and commitment statement by an independent director candidate for a company's board. It includes numerous compliance affirmations related to laws, regulations, and stock exchange rules, as well as personal qualifications and commitments. There is no financial data, no report of financial results, no voting results, no meeting materials, and no announcement of a report publication. The document is a formal statement related to board/management information, specifically concerning the nomination and qualifications of an independent director candidate. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is 2788 characters, which is consistent with a detailed declaration rather than a brief announcement or a full report.
2025-06-20 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.